Guangxi Liuzhou Pharm Co Ltd Total Liabilities
Guangxi Liuzhou Pharm Co Ltd total liabilities. Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has total liabilities worth CN¥13.05 Billion CNY (≈ $1.91 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 603368 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Total liabilities of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 603368 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Guangxi Liuzhou Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Frequentis AG
VI:FQT
|
Austria | €256.53 Million |
|
Insigma
SHG:600797
|
China | CN¥1.81 Billion |
|
Zhongnongfa Seed Industry Group Co Ltd
SHG:600313
|
China | CN¥2.08 Billion |
|
Unitech Printed Circuit Board Corp
TW:2367
|
Taiwan | NT$15.71 Billion |
|
BLS International Services Limited
NSE:BLS
|
India | Rs9.00 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥1.23 Billion |
|
NWPX Infrastructure, Inc.
NASDAQ:NWPX
|
USA | $233.30 Million |
|
Emerald Expositions Events Inc
NYSE:EEX
|
USA | $847.80 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Guangxi Liuzhou Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Guangxi Liuzhou Pharm Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Guangxi Liuzhou Pharm Co Ltd Total Liabilities Ratios Explained
Guangxi Liuzhou Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangxi Liuzhou Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
The table below shows the annual total liabilities of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥13.33 Billion ≈ $1.95 Billion |
+1.80% |
| 2023-12-31 | CN¥13.10 Billion ≈ $1.92 Billion |
+6.98% |
| 2022-12-31 | CN¥12.24 Billion ≈ $1.79 Billion |
+21.58% |
| 2021-12-31 | CN¥10.07 Billion ≈ $1.47 Billion |
+7.53% |
| 2020-12-31 | CN¥9.36 Billion ≈ $1.37 Billion |
+28.25% |
| 2019-12-31 | CN¥7.30 Billion ≈ $1.07 Billion |
+27.51% |
| 2018-12-31 | CN¥5.73 Billion ≈ $837.83 Million |
+43.66% |
| 2017-12-31 | CN¥3.99 Billion ≈ $583.21 Million |
+31.05% |
| 2016-12-31 | CN¥3.04 Billion ≈ $445.02 Million |
+3.29% |
| 2015-12-31 | CN¥2.94 Billion ≈ $430.85 Million |
+14.94% |
| 2014-12-31 | CN¥2.56 Billion ≈ $374.86 Million |
+16.61% |
| 2013-12-31 | CN¥2.20 Billion ≈ $321.47 Million |
+33.08% |
| 2012-12-31 | CN¥1.65 Billion ≈ $241.56 Million |
+27.04% |
| 2011-12-31 | CN¥1.30 Billion ≈ $190.15 Million |
-- |
About Guangxi Liuzhou Pharm Co Ltd
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, and test reagents through online pharmacies and terminal physical pharmacies. The company was founded in 1981 and is based in Liuzhou, China.